FDA Inspection 783865 — Sanofi Pasteur Limited
The FDA completed an inspection of Sanofi Pasteur Limited on April 25, 2012 in North York. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Biologics.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- April 25, 2012
- Fiscal Year
- 2012
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- North York (Canada)